Epigral Ltd announced its Q2 FY26 financial results, reporting a revenue of 589 Crore, down from 632 Crore in the same quarter last year, with PAT at 51 Crore versus 81 Crore in Q2 FY25; the drop was attributed to lower sales and an extended monsoon affecting product volume.